首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1606519

全球遠距病患監護市場 - 2024-2031

Global Remote Patient Monitoring Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球遠距病患監護市場規模達到502億美元，預計到2031年將達到2,510億美元，2024-2031年預測期間複合年成長率為22.4%。

遠端患者監測是指使用數位技術、醫療設備和電信系統在傳統臨床環境之外（例如在家中或社區環境中）監測和管理患者的健康狀況。遠端患者監測涉及連續或定期收集與生命徵象、症狀或慢性病相關的患者資料，然後將其傳輸給醫療保健提供者進行審查、分析和後續護理。監控設備收集的資料透過安全的無線通訊技術傳輸到醫療保健提供者或監控平台。這些資料可以包括心率、血壓、血糖值、氧飽和度等指標。

由於對高效慢性病管理的需求、全球向以患者為中心的護理模式的轉變以及遠端患者監測的日益普及，對遠端患者監測的需求正在快速成長。例如，Vivalink 對美國各地醫療服務提供者的調查結果顯示，84% 的受訪者目前正在使用遠距患者監護，並計劃在2024 年增加其使用量。使用遠距患者監護。

市場動態：

驅動程式和限制

慢性病盛行率上升

慢性病盛行率的上升極大地推動了遠距患者監護市場的成長，預計將在預測期內推動該市場的發展。慢性疾病通常需要定期監測關鍵生命徵象，例如血壓、血糖水平、心率和血氧飽和度。遠端患者監測解決方案使患者能夠在家中持續追蹤自己的健康狀況，並將資料傳輸給醫療保健提供者進行持續評估。

例如，根據國際糖尿病聯盟 (IDF) 的數據，全球有超過 4.63 億成年人患有糖尿病，對連續血糖監測 (CGM) 設備的需求正在飆升。 Dexcom 和 Abbott 等公司推出了 Dexcom G6 和 Freestyle Libre 等產品，廣泛用於遠端監測血糖水平。這些系統允許患者接收即時血糖讀數並與醫療保健提供者共享資料，從而實現更有效的糖尿病管理。

據泛美衛生組織稱，高血壓影響著全球超過 30% 的成年人口，全球人口超過 10 億。使用歐姆龍血壓計等設備遠端監測血壓已變得越來越普遍。遠端患者監測解決方案可以進行持續追蹤，幫助患者和醫療服務提供者更有效地管理疾病，避免中風或心臟衰竭等併發症。

心血管疾病是全球主要死亡原因，根據 CDC 的數據，每 33 秒就有一人死於心血管疾病。 2022年，702,880人死於心臟病。這相當於每 5 人死亡就有 1 人死亡。遠端患者監測設備（例如用於連續心電圖監測的 Medtronic 的 MiniMed 胰島素幫浦和 iRhythm 的 Zio Patch）透過追蹤關鍵指標並確保在需要時進行早期干預，有助於減少就診次數。

缺乏患者的接受度和參與度

缺乏患者接受度和參與度是遠距患者監護市場成長的重大障礙。雖然遠距患者監測提供了許多好處，例如改善慢性病管理和降低醫療成本，但許多患者仍然難以完全接受這些技術。與此問題相關的主要挑戰包括技術障礙、缺乏理解或意識以及隱私問題，所有這些都會影響患者的採用和參與。

許多患者，尤其是老年人，發現遠距患者監護設備和健康平台難以使用。這些技術通常需要一定程度的數位素養，對於那些不熟悉數位工具的人來說，設定過程或持續使用可能看起來很複雜或令人沮喪。

例如，雖然遠端健康監測越來越受歡迎，但作為遠端患者監測的關鍵人群的老年患者可能會在採用新技術方面遇到困難。老年人缺乏舒適感和對科技的熟悉程度阻礙了其廣泛採用，特別是在治療心臟病和糖尿病等慢性疾病方面。

由於擔心資料隱私和安全，患者可能會猶豫是否採用遠距患者監護解決方案。透過網路傳輸敏感健康資料會引發與資料外洩、未經授權的存取或濫用個人健康資訊相關的問題。這些擔憂可能會破壞信任並阻礙患者充分參與遠距患者監護技術。

例如，根據 HIPAA 雜誌報導，2023 年 8 月，發現有 2,300 萬筆醫療記錄被洩露。在過去 12 個月中，平均每月有 9,989,003 筆醫療記錄被洩露。截至 2024 年 8 月 31 日的一年內，已發生 491 起資料外洩事件，涉及 500 筆或更多記錄，已知至少有 58,668,002 筆記錄已外洩。目前，2024 年的平均外洩規模為 119,487 筆記錄，中位外洩規模為 4,109 筆記錄。

Remote patient monitoring refers to the use of digital technologies, medical devices and telecommunication systems to monitor and manage a patient's health outside of traditional clinical settings, such as at home or in a community setting. Remote patient monitoring involves the continuous or periodic collection of patient data related to vital signs, symptoms or chronic conditions, which is then transmitted to healthcare providers for review, analysis, and follow-up care. The data collected by the monitoring devices is transmitted via secure, wireless communication technologies to healthcare providers or monitoring platforms. The data can include metrics like heart rate, blood pressure, blood glucose levels, oxygen saturation and more.

The demand for remote patient monitoring is rapidly growing, driven by the need for efficient chronic disease management, the global shift toward more patient-centric care models and the rising adoption of remote patient monitoring. For instance, results of a Vivalink survey of providers across the U.S. revealed that 84% of the total respondents currently using remote patient monitoring and also plan to increase their usage in 2024. Additionally, according to Medscape, it is estimated that more than 60 million people in the U.S. will have used remote patient monitoring in 2024.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is significantly driving the growth of the remote patient monitoring market and is expected to drive the market over the forecast period. Chronic diseases often require regular monitoring of key vital signs, such as blood pressure, blood glucose levels, heart rate and oxygen saturation. Remote patient monitoring solutions enable patients to continuously track their health at home and transmit the data to healthcare providers for ongoing assessment.

For instance, with over 463 million adults worldwide living with diabetes, according to the International Diabetes Federation (IDF), the demand for continuous glucose monitoring (CGM) devices is soaring. Companies like Dexcom and Abbott have introduced products such as the Dexcom G6 and the Freestyle Libre, which are widely used for remote monitoring of glucose levels. These systems allow patients to receive real-time glucose readings and share data with healthcare providers, enabling more effective diabetes management.

According to the Pan American Health Organization, hypertension affects more than 30% of the adult population worldwide, more than one billion people around the world. Monitoring blood pressure remotely has become increasingly common with devices like Omron's Blood Pressure Monitor. Remote patient monitoring solutions allow for continuous tracking, which helps patients and providers manage the disease more effectively, avoiding complications like stroke or heart failure.

Cardiovascular diseases are the leading cause of death globally, according to the CDC, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. Remote patient monitoring devices such as Medtronic's MiniMed insulin pumps and iRhythm's Zio Patch for continuous ECG monitoring help reduce hospital visits by tracking critical metrics and ensuring early intervention when needed.

Lack of patient acceptance and engagement

The lack of patient acceptance and engagement is a significant barrier to the growth of the remote patient monitoring market. While remote patient monitoring offers numerous benefits, such as improved chronic disease management and reduced healthcare costs, many patients still struggle to fully embrace these technologies. The key challenges related to this issue include technological barriers, lack of understanding or awareness and privacy concerns, all of which impact patient adoption and engagement.

Many patients, particularly older adults, find remote patient monitoring devices and health platforms difficult to use. These technologies often require a certain level of digital literacy, and for those who are not familiar with digital tools, the setup process or ongoing usage may seem complex or frustrating.

For instance, while remote health monitoring is gaining traction, older patients, who are a key demographic for remote patient monitoring, may struggle with adopting new technologies. This lack of comfort and technological familiarity among seniors hampers the widespread adoption, especially for managing chronic conditions like heart disease and diabetes.

Patients may be hesitant to adopt remote patient monitoring solutions due to concerns about data privacy and security. The transmission of sensitive health data over the internet raises issues related to data breaches, unauthorized access or misuse of personal health information. These concerns can undermine trust and discourage patients from fully engaging with remote patient monitoring technologies.

For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records are noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month. In the year to August 31, 2024, there have been 491 data breaches of 500 or more records, and at least 58,668,002 records are known to have been breached. The average breach size in 2024 is currently 119,487 records and the median breach size is 4,109 records.

Segment Analysis

The global remote patient monitoring market is segmented based on type, technology, application, end-user and region.

Type:

Wearable devices segment is expected to dominate the remote patient monitoring market share

The wearable devices segment is expected to dominate the global remote patient monitoring market due to their convenience, real-time data collection and continuous monitoring capabilities. Wearable devices are often the most user-friendly remote patient monitoring solutions, enabling patients to manage their health proactively while providing healthcare providers with consistent data for timely intervention.

Wearable devices are typically non-intrusive and easy to use, which makes them highly accessible to a wide range of patients. They allow for continuous monitoring of vital signs, such as heart rate, blood pressure, blood oxygen levels, and physical activity without the need for frequent hospital visits. For instance, Fitbit and Apple Watch are two widely used wearable devices that continuously track heart rate, steps and sleep patterns. These devices are designed to be worn throughout the day, giving users consistent feedback on their health while being minimally disruptive to their daily routine.

Wearables also help patients track their health, which motivates them to engage with their treatment plans. These devices often provide users with feedback, reminders and goals, fostering better self-management of chronic conditions and encouraging healthier behaviors. Thus, the market players are focusing on the development of remote patient monitoring devices with enhanced features.

For instance, in July 2024, Georgia-based KORE and Australian company mCare Digital launched a smartwatch for virtual patient monitoring called mCareWatch 241. The watch features an SOS setting that enables wearers to obtain emergency assistance, call capabilities, GPS tracking, reminders, a heart rate monitor, speed dialing, fall detection, a pedometer, a geo-fence alarm, non-movement detection and a mobile app and web dashboard.

Geographical Analysis

North America is expected to hold a significant position in the remote patient monitoring market share

North America is expected to hold the largest market share in the global remote patient monitoring market. North America, especially the United States, has a significant burden of chronic diseases such as diabetes, hypertension, heart disease and obesity, which drives the demand for remote monitoring solutions.

For instance, according to the CDC, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Remote patient monitoring helps manage these conditions by providing continuous monitoring, reducing hospital visits and enabling early interventions.

North America is a leader in digital health innovation, with widespread adoption of wearable devices, telehealth platforms and smart health technologies. This creates a favorable environment for remote patient monitoring solutions to thrive, as patients are increasingly willing to use technology to manage their health. For instance, the Apple Watch and Fitbit have become mainstream devices in North America, with features like heart rate monitoring, ECG and sleep tracking that are often used in conjunction with remote patient monitoring applications.

Asia-Pacific is growing at the fastest pace in the remote patient monitoring market

The Asia-Pacific region is experiencing the fastest growth in the remote patient monitoring market, owing to the strong presence of market players and innovative product launches, technological advancements and rising chronic disease prevalence. Asia Pacific especially India, Japan and China witnessed rapid growth in smartphone adoption, which has created a favorable environment for the use of wearables and mobile health applications. These technologies allow manufacturers to develop innovative wearable devices for remote patient monitoring.

For instance, Mindray launched the mWear system, an all-new wearable patient monitoring solution that enables an efficient workflow to continually monitor patient conditions and deliver advanced patient-centric care. mWearTM supports comprehensive and precise measurements of vital signs including ECG, oxygen saturation, noninvasive blood pressure, respiration rate, pulse rate and temperature.

Competitive Landscape

The major global players in the remote patient monitoring market include Apple Inc., Koninklijke Philips N.V., Samsung SDS America, Inc., Humworld Inc., Medtronic plc, Siemens Healthineers AG, GE HealthCare, Fitbit (Google), Abbott Laboratories, Qardio, Inc. and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global remote patient monitoring market report delivers a detailed analysis with 70 key tables, more than 69 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Lack of Patient Acceptance and Engagement
  - 4.1.1.2. Increasing number of organ transplants
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Patient Acceptance and Engagement
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Wearable Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Smartwatches and Fitness Trackers
- 6.2.4. Smart Clothing
- 6.2.5. Wearable ECG Monitors
- 6.2.6. Patches
- 6.2.7. Others
6.3. Non-Wearable Devices
- 6.3.1. Blood Pressure Monitors
- 6.3.2. Glucose Monitoring Devices
- 6.3.3. ECG Monitors
- 6.3.4. Pulse Oximeters
- 6.3.5. Thermometers
- 6.3.6. Others
6.4. Software Services

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Wearable Technology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bluetooth and Wi-Fi Technology
7.4. Artificial Intelligence (AI)
7.5. Mobile Health (mHealth)
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Chronic Disease Management*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Post-Operative Care
8.4. Maternal Health
8.5. Mental Health
8.6. Emergency Care
8.7. General Health and Wellness
8.8. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Homecare Settings
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Apple Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Koninklijke Philips N.V.
12.3. Samsung SDS America, Inc.
12.4. Humworld Inc.
12.5. Medtronic plc
12.6. Siemens Healthineers AG
12.7. GE HealthCare
12.8. Fitbit (Google)
12.9. Abbott Laboratories
12.10. Qardio, Inc.

LIST NOT EXHAUSTIVE